Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Association of BCCIP with 53BP1 in triple-negative and nontriple-negative breast cancers

From: Roles of BCCIP deficiency in mammary tumorigenesis

Breast cancer BCCIP (−) BCCIP (+) Total cases p value
Triple negative
 53BP1 (−) 40 15 55 (43.0%) 3.63 × 10–7
 53BP1 (+) 20 53 73 (57.0%)
 Subtotal 60 (46.9%) 68 (53.1%) 128  
Nontriple negative
 53BP1 (−) 2 4 6 (1.9%) 0.58
 53BP1 (+) 71 231 302 (98.1%)
 Subtotal 73 (23.7%) 235 (76.3) 308  
  1. BCCIP BRCA2 and CDKN1A interacting protein